Hydroxychloroquine sulfate（King Hussein Cancer Center） | Interleukin Related interleukin-related.com

Product Name :
Hydroxychloroquine sulfate（King Hussein Cancer Center）

Search keywords :
Hydroxychloroquine (sulfate)

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Immunostimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
King Hussein Cancer Center

Active Company_Name :
King Hussein Cancer Center

Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATG5 Antibody
Raf1 Antibody
Hexokinase I Antibody (YA739): Hexokinase I Antibody (YA739) is a non-conjugated and Mouse origined monoclonal antibody about 102 kDa, targeting to Hexokinase I (6B8). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts